MolNFT v2 · #39767 · protein
2I46: Crystal structure of human TPP1
2I46 · Adrenocortical dysplasia protein homolog: “Crystal structure of human TPP1”. X-ray diffraction at 2.7, 2 pockets (best druggability 0.39). MolNFT v2 #39767 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

- PDB
- 2I46
- Type
- protein
- Length
- 286 residues
- Chains
- 2
- Method
- x-ray diffraction
- Authors
- Wang, F., Podell, E.R., Zaug, A.J., Yang, Y.T., Baciu, P., Else, T., Hammer, G.D., Cech, T.R., Lei, M.
- Deposited
- 08/21/06
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.7
- Source
- Homo sapiens
- Molecule
- Adrenocortical dysplasia protein homolog
- UniProt
- Q96AP0
- Pockets
- 2 · best druggability 0.39
Structure
x-ray diffraction · resolution 2.7 · 2 distinct chains · 18% helix, 37% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Adrenocortical dysplasia protein homolog | protein | 152 | 16% helix, 36% strand | Q96AP0 |
| B | Adrenocortical dysplasia protein homolog | protein | 134 | 20% helix, 39% strand | Q96AP0 |
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 70 | 0.39 | 0.79 | 17 | empty |
| 2 | 106 | 0.37 | 0.75 | 24 | empty |
Interfaces
1 interface between chains.
- A–B · 1430 Ų buried · 19 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q96AP0
- Elsewhere: RCSB PDB 2I46 · PDBe 2I46 · UniProt Q96AP0
Other records of 2I46
- 2I46-2 · MolNFT v1 / PDB · Crystal structure of human TPP1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.